We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioAlliance Pharma’s Sitavig® Receives Market Authorization in the US

News   Apr 16, 2013

 
BioAlliance Pharma’s Sitavig® Receives Market Authorization in the US
 
 
 

RELATED ARTICLES

Discovering the Parameters That Govern the Encapsulation of Drugs

News

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

Device Would Allow TB Dosing to Switch From Daily to Monthly

News

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE